Risperdal Consta Priced Aggressively; J&J Sets High Premium To Zyprexa

Johnson & Johnson's Risperdal Consta (risperidone) is being launched at approximately twice the daily cost of Lilly's market-leading antipsychotic Zyprexa (olanzapine)